These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3879338)

  • 41. Effect of chronic oral nicotine on dopaminergic function in the MPTP-treated mouse.
    Sershen H; Hashim A; Wiener HL; Lajtha A
    Neurosci Lett; 1988 Nov; 93(2-3):270-4. PubMed ID: 3266524
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Age-dependent effects of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP).
    Jarvis MF; Wagner GC
    Neuropharmacology; 1985 Jun; 24(6):581-3. PubMed ID: 3875054
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A high dose of MPTP overcomes the protective effect of selegiline against dopaminergic neurotoxicity.
    Fuller RW; Hemrick-Luecke SK
    J Pharm Pharmacol; 1989 Jul; 41(7):492-3. PubMed ID: 2570859
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Regional and temporal effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on dopamine uptake sites in mouse brain.
    Donnan GA; Kaczmarczyk SJ; McKenzie JS; Rowe PJ; Kalnins RM; Mendelsohn FA
    J Neurol Sci; 1987 Nov; 81(2-3):261-71. PubMed ID: 3501002
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevention of dopaminergic toxicity of MPTP in mice by phenylethylamine, a specific substrate of type B monoamine oxidase.
    Melamed E; Youdim MB
    Br J Pharmacol; 1985 Nov; 86(3):529-31. PubMed ID: 3877535
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dopamine D1 receptor and dopamine D2 receptor binding activity changes during chronic administration of nicotine in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice.
    Wiener HL; Lajtha A; Sershen H
    Neuropharmacology; 1989 May; 28(5):535-7. PubMed ID: 2657481
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reduction of muscarinic cholinergic receptors in mouse striatum by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its recovery by levodopa treatment.
    Ogawa N; Sora YH; Sato H; Mizukawa K
    Res Commun Chem Pathol Pharmacol; 1987 Jul; 57(1):133-6. PubMed ID: 3499644
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role for monoamine oxidase-A (MAO-A) in the bioactivation and nigrostriatal dopaminergic neurotoxicity of the MPTP analog, 2'Me-MPTP.
    Kindt MV; Youngster SK; Sonsalla PK; Duvoisin RC; Heikkila RE
    Eur J Pharmacol; 1988 Feb; 146(2-3):313-8. PubMed ID: 3131149
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity: partial protection against striato-nigral dopamine depletion in C57BL/6J mice by cigarette smoke exposure and by beta-naphthoflavone-pretreatment.
    Shahi GS; Das NP; Moochhala SM
    Neurosci Lett; 1991 Jun; 127(2):247-50. PubMed ID: 1881637
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced dopamine D2 receptor hypersensitivity in the mouse is transient.
    Peroutka SJ; DeLanney L; Irwin I; Ison PJ; Ricaurte G; Schlegel JR; Langston JW
    Res Commun Chem Pathol Pharmacol; 1985 May; 48(2):163-71. PubMed ID: 3875136
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Potent neurotoxic fluorinated 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs as potential probes in models of Parkinson disease.
    Riachi NJ; Arora PK; Sayre LM; Harik SI
    J Neurochem; 1988 Apr; 50(4):1319-21. PubMed ID: 3258018
    [TBL] [Abstract][Full Text] [Related]  

  • 52. On the mechanisms underlying 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: the effect of perinigral infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, its metabolite and their analogs in the rat.
    Harik SI; Schmidley JW; Iacofano LA; Blue P; Arora PK; Sayre LM
    J Pharmacol Exp Ther; 1987 May; 241(2):669-76. PubMed ID: 2437293
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neurochemical evidence for agmatine modulation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity.
    Gilad GM; Gilad VH; Finberg JP; Rabey JM
    Neurochem Res; 2005; 30(6-7):713-9. PubMed ID: 16187208
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neurochemical and functional consequences following 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) and methamphetamine.
    Jarvis MF; Wagner GC
    Life Sci; 1985 Jan; 36(3):249-54. PubMed ID: 3871245
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Repeated administration of N-methyl-4-phenyl 1,2,5,6-tetrahydropyridine to rats is not toxic to striatal dopamine neurones.
    Boyce S; Kelly E; Reavill C; Jenner P; Marsden CD
    Biochem Pharmacol; 1984 Jun; 33(11):1747-52. PubMed ID: 6610420
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis and toxicity toward nigrostriatal dopamine neurons of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) analogues.
    Fries DS; de Vries J; Hazelhoff B; Horn AS
    J Med Chem; 1986 Mar; 29(3):424-7. PubMed ID: 3485197
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diphenylhydantoin and phenobarbital suppress the dopaminergic neurotoxicity of MPTP in mice.
    Melamed E; Martinovits G; Pikarsky E; Rosenthal J; Uzzan A
    Eur J Pharmacol; 1986 Sep; 128(3):255-7. PubMed ID: 3491762
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Strain differences in systemic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in mice correlate best with monoamine oxidase activity at the blood-brain barrier.
    Riachi NJ; Harik SI
    Life Sci; 1988; 42(23):2359-63. PubMed ID: 3259663
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Depletion of striatal dopamine by the N-oxide of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Lau YS; Fung YK; Trobough KL; Cashman JR; Wilson JA
    Neurotoxicology; 1991; 12(2):189-99. PubMed ID: 1956580
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Aging and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of dopaminergic neurons in the substantia nigra.
    Ricaurte GA; Irwin I; Forno LS; DeLanney LE; Langston E; Langston JW
    Brain Res; 1987 Feb; 403(1):43-51. PubMed ID: 3493827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.